Head of Molecular Oncology Laboratory, General University Hospital Research Foundation
September 13 at 10:00am CEST, 9:00am BST
Webinar Series Part 2: The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research
Speakers
-
Dr. Gorka Alkorta-Aranburu
Codirector, Genetics of solid and hereditary tumors, University of Navarra -
Matteo Allegretti, PhD
Translational Oncology Research Unit, RCSS Regina Elena National Cancer InstituteBIOGRAPHY
Event Date & Time
September 13 at 10:00am CEST, 9:00am BST
*Webinar airing too early or too late for you? This webinar will also be available:
September 13 at 9:30am IST, 12:00pm CST
https://www.labroots.com/ms/webinar/dpcr-liquidbiopsy-panel-2-ist
and
September 13 at 10:00am PDT, 12:00pm CDT, 1:00 EDT
and
September 13 at 10:00am PDT, 12:00pm CDT, 1:00 EDT
Abstract
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsies are less risky, painful, and costly, and are increasingly being used to analyze biomarkers in liquid samples, such as blood. Recent advances in genomic technologies, such as digital PCR (dPCR) and next-generation sequencing (NGS), have enabled researchers to more comprehensively detect and study cancer-related mutations, even when they are very rare. With this panel of key opinion leaders in the liquid biopsy space, we dive deeper into the impact of genomics and genomics technologies on the current and future of liquid biopsy clinical research and cancer management. At Thermo Fisher Scientific we are committed to developing robust sample preparation solutions for cell-free nucleic acids and highly sensitive liquid biopsy assays utilizing both dPCR and targeted NGS to enable cancer driver identification, serial monitoring, and potential recurrence detection.
On-demand webinar Part 1: Enter event in auditorium to access
Webinar Part 2: Register to attend
Learning Objectives
- Discuss the features of digital PCR and its advantages in liquid biopsy research
- Understand the ways dPCR can be used to support precision medicine research
- Discuss the types of analytes used for dPCR analysis
- Define the current state of dPCR for routine monitoring of cancer patients and future trends
For Research Use Only. Not for use in diagnostic procedures.
Webinars will be available for unlimited on-demand viewing after live event.
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 04, 2025 | 8:00 AM
Accurate and timely diagnosis of inborn errors of immunity (IEI) is essential for improving patient outcomes. Flow cytometry is widely recommended for robust and sensitive IEI screening; how...
DEC 05, 2025 | 1:00 PM
C.E. CREDITS
Explore the evolution, methods, and limitations of mixing studies in detecting factor deficiencies and lupus anticoagulants in coagulation testing....
DEC 09, 2025 | 10:00 AM
Antibody-drug conjugates (ADCs) are transforming oncology by combining the precision of monoclonal antibodies with the potency of cytotoxic drugs. Yet, developing effective ADCs requires ove...
DEC 09, 2025 | 10:00 AM
Ensuring quality and compliance is at the core of every successful clinical laboratory. This webinar brings together CAP expert Daniel and Christie, QA leader from Burning Rock, to explore t...
DEC 10, 2025 | 2:00 PM
Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in Europe and the U.S.—yet when detected early, the 5-year survival rate jumps to 91% . While colonoscopy r...
DEC 10, 2025 | 8:00 AM
Mass spectrometry (MS)-based proteomic biomarker discovery pipeline commonly begins with large-scale profiling techniques detecting thousands of candidate biomarkers. Efficiently triaging th...
Loading Comments...